Then, we also checked the potential value of ACSL3 and RETN as NSCLC prognostic biomarkers using The Human Protein Atlas website together with The Pathology Atlas online tool (https://www.proteinatlas.org/humanproteome/pathology), that contains mRNA data from TCGA study and protein expression data from different forms of human cancer [40, 41, 42]. This evidence concerns the gene ACSL3 and cancer.